Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Etoposide × Gynecologic × Clear all

Phase

Status

Completed 19 Unknown 9 Terminated 4 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 32 Lymphoid 28 Other hematologic neoplasm 14 CNS 10 Genitourinary 6 Endocrine 5 Other solid neoplasm 4 Plasma cell 3 Sarcoma 1 NET 1 Myeloid 1 Gynecologic 1 Gastrointestinal 1 Breast 1

Conditions

Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1

Interventions

Paclitaxel 66 pembrolizumab 54 Carboplatin 54 Bevacizumab 49 Cisplatin 34 Specimen Handling 29 Drug Therapy 22 Blood Specimen Collection 20 olaparib 19 Magnetic Resonance Spectroscopy 17 Biopsy 16 Cyclophosphamide 15 niraparib 12 fludarabine 12 Taxes 12 Letrozole 12 Gemcitabine 12 abemaciclib 10 Fulvestrant 10 liposomal doxorubicin 9 dostarlimab 9 Radiotherapy 9 Nivolumab 9 Injections 8 Docetaxel 8 Brachytherapy 8 toripalimab 7 mirvetuximab soravtansine 7 lenvatinib 7 camrelizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02429687 2023-04-25

MOGCT-01

Shandong University

Phase 3 Recruiting

Ovarian Germ Cell Cancer, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡